Table 1.
ΔEsint | ΔG(T)th | ΔEelst | ΔGdrc | ΔGsol | ΔGtot | |
---|---|---|---|---|---|---|
B3LYP/6-31G* | ||||||
Piperidine | 238.4 | −9.7 | 54.1 | −0.3 | 53.9 | 282.6 |
N-Me piperidine | 241.6 | −9.7 | 49.7 | −0.3 | 49.4 | 281.3 |
Piperazineb | 237.2 | −9.1 | 53.7 | −0.3 | 53.5 | 281.6 |
B3LYP/6-311++G** | ||||||
Piperidine | 235.4 | −9.7 | 53.7 | −0.2 | 53.5 | 279.2 |
N-Me piperidine | 239.5 | −9.8 | 49.3 | −0.3 | 49.0 | 278.8 |
Piperazineb | 233.7 | −9.0 | 53.5 | −0.2 | 53.3 | 278.0 |
B3P86/6-311++G** | ||||||
Piperidine | 236.3 | −9.8 | 53.6 | −0.2 | 53.4 | 279.9 |
N-Me piperidine | 240.2 | −9.8 | 49.2 | −0.3 | 48.9 | 279.3 |
Piperazineb | 234.6 | −9.1 | 53.4 | −0.2 | 53.2 | 278.7 |
ΔEsint |
ΔGsol | |||||
MP2 aug-cc-pvdz |
MP2 aug-cc-pvtz/SP |
MP2CBS | QCISD(T) aug-cc-pvdz/SP |
QCISD(T)c CBS |
||
Piperidine | 233.2 | 233.7 | 233.9 | 234.8 | 235.4 | 53.6 |
N-Me piperidine | 237.6 | 237.9 | 238.1 | 239.4 | 239.8 | 49.2 |
Piperazine | 231.3 | 231.8 | 232.0 | 232.9 | 233.5 | 53.7 |
Energy terms in kcal/mol. By approximating ΔGotot as ΔGtot, ΔGtot was calculated according to eq. 3.
Entropy decreased by 0.41 kcal/mol for the neutral piperazine due to a rotational symmetry number of 2 for a species with C2h symmetry.
The ΔE values were calculated as ΔE (QCISD(T)/CBS) = ΔE(MP2CBS)+(ΔE(QCISDT(aug-cc-pvdz))-ΔE(MP2(aug-cc-pvdz))).The ΔE(MP2CBS) values were estimated on the basis of aug-cc-pvdz optimization and aug-cc-pvtz single-point calculations. MP2 thermal corrections deviate from the B3LYP/6-311++G** values by up to −0.1 kcal/mol.